Skip to main content
. 2024 Jan 8;14:4. doi: 10.1186/s13613-023-01213-x

Table 3.

Treatment and prognosis of attacks requiring orotracheal intubation versus attacks not requiring orotracheal intubation

Hospitalization duration, days 21 (7–48) 74 (55–98) 21 (7–36) 0.061
Delay from attack first symptoms to hospitalization, days 11.5 (4–21.2) 18 (7.5–32.5) 10.5 (3.8–21) 0.779
ICU hospitalization: yes 28 (38.4) 8 (100) 20 (27.4) -
 If yes: ICU duration, days, median (P25;P75) (N attacks with ICU hospitalization) 25 (12;40) (28) 44.5 (40;57) (8) 17 (7;28) (20) 0. 094
 If yes: SAPS II, median (P25;P75) (N attacks with ICU hospitalization) 13 (6;18.25) (28) 19 (17;19) (8) 13 (6;13) (20) 0.891
 Intubation duration, days 27.00 [17.00, 41.50]
 Aspiration pneumonia 3 (37.5)
 Ventilator-associated pneumonia 5 (62.5)
 Tracheostomy 2 (37.5)
Medical treatment
 Total dose of corticosteroids (grams) 7.5 (5;10) 10 (8;10) 7 (5;10) 0.677
 Delay from first symptoms to IV corticosteroids, days 14 (7–32) 24.5 (13–58.5) 13 (6–30) 0.701
 TPE (yes or no) 35 (47.9) 8 (100) 27 (41.5)
 Number of TPE 6 (5–8) 7.5 (6.3–10) 6 (5–8) 0.911
 Delay from first symptoms to TPE, days 21.5 (12.5–44) 28 (16.5–82) 20 (9.3–38) 0.599
Outcomes
 Death during hospitalization 1 (1.3) 1 (12.5) 0 (0.0)
 EDSS 3 months after attack onset, median (IQR) (NA) 4.0 (2.5–7.0) (13) 7.0 (6.0–9.0) (0) 3.5 (2.5–6.5) (13) 0. 402
 EDSS 6 months after attack onset 3.5 (2.0–7.0) (14) 5.5 (2.5–9.0) (0) 3.5 (2.5–6.5) (14) 0.574
 EDSS 12 months after attack onset (0) 3.5 (2.0–6.5) (0) 5.0 (2.0–9.0) (0) 3.5 (2.0–6.0) (0) 0.524
 EDSS < 4, 12 months after attack 38 (52.1) 4 (50.0) 34 (52.3) 0.476
 Recurrent attack during the following year 29 (39.7) 1 (12.5) 28 (43.1) 0.624
 Patient working 12 months after attack 22 (33.8) 2 (28.5) 20 (34.5) 0.028
 Modified Rankin scale 12 months after the attack 2 [1, 3] 2 [1, 3] 2 [1, 3.5] 0.549
 Unfavorable attack recoverya at 12 months 17 (24.3) 2 (25.0) 15 (24.2) (3) 0.468

Results are expressed in median (interquartile range) or N (%) unless otherwise specified

NA number of observations non available, OTI orotracheal intubation, TPE therapeutic plasma exchange, EDSS expanded disability severity score

aUnfavorable attack recovery = defined as modified Rankin score (mRS) > 2 at 3 months for patients with initial mRS ≤ 2 or an increase of ≥ 1 point in mRS for patients with initial mRS > 2